Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125950592 | 12595059 | 2 | F | 20110507 | 20160818 | 20160726 | 20160902 | EXP | US-WEST-WARD PHARMACEUTICALS CORP.-US-H14001-16-01287 | WESTWARD | 43.40 | YR | M | Y | 79.90000 | KG | 20160902 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125950592 | 12595059 | 1 | PS | PREDNISONE. | PREDNISONE | 1 | Oral | Y | 80352 | ||||||||||
| 125950592 | 12595059 | 2 | SS | HEPARIN | HEPARIN SODIUM | 1 | Unknown | 17037 | |||||||||||
| 125950592 | 12595059 | 3 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 0 | |||||||||||
| 125950592 | 12595059 | 4 | SS | SIROLIMUS. | SIROLIMUS | 1 | Unknown | 0 | |||||||||||
| 125950592 | 12595059 | 5 | SS | LOVENOX | ENOXAPARIN SODIUM | 1 | Unknown | 0 | |||||||||||
| 125950592 | 12595059 | 6 | C | NIFEDIPINE. | NIFEDIPINE | 1 | Unknown | 0 | |||||||||||
| 125950592 | 12595059 | 7 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | 0 | |||||||||||
| 125950592 | 12595059 | 8 | C | LASIX | FUROSEMIDE | 1 | Unknown | 0 | |||||||||||
| 125950592 | 12595059 | 9 | C | IMMUNOGLOBULIN HUMAN NORMAL | HUMAN IMMUNOGLOBULIN G | 1 | Unknown | 0 | |||||||||||
| 125950592 | 12595059 | 10 | C | POSACONAZOLE | POSACONAZOLE | 1 | Unknown | 0 | |||||||||||
| 125950592 | 12595059 | 11 | C | DITROPAN | OXYBUTYNIN CHLORIDE | 1 | Unknown | 0 | |||||||||||
| 125950592 | 12595059 | 12 | C | ATOVAQUONE. | ATOVAQUONE | 1 | Unknown | 0 | |||||||||||
| 125950592 | 12595059 | 13 | C | FLUTICASONE/SALMETEROL | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 0 | |||||||||||
| 125950592 | 12595059 | 14 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Unknown | 0 | |||||||||||
| 125950592 | 12595059 | 15 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Unknown | 0 | |||||||||||
| 125950592 | 12595059 | 16 | C | BUDESONIDE. | BUDESONIDE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125950592 | 12595059 | 1 | Graft versus host disease |
| 125950592 | 12595059 | 2 | Product used for unknown indication |
| 125950592 | 12595059 | 3 | Graft versus host disease |
| 125950592 | 12595059 | 4 | Graft versus host disease |
| 125950592 | 12595059 | 5 | Thrombosis prophylaxis |
| 125950592 | 12595059 | 6 | Product used for unknown indication |
| 125950592 | 12595059 | 7 | Product used for unknown indication |
| 125950592 | 12595059 | 8 | Product used for unknown indication |
| 125950592 | 12595059 | 9 | Product used for unknown indication |
| 125950592 | 12595059 | 10 | Product used for unknown indication |
| 125950592 | 12595059 | 11 | Product used for unknown indication |
| 125950592 | 12595059 | 12 | Product used for unknown indication |
| 125950592 | 12595059 | 13 | Product used for unknown indication |
| 125950592 | 12595059 | 14 | Product used for unknown indication |
| 125950592 | 12595059 | 15 | Product used for unknown indication |
| 125950592 | 12595059 | 16 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125950592 | 12595059 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125950592 | 12595059 | Arthralgia | |
| 125950592 | 12595059 | Atelectasis | |
| 125950592 | 12595059 | Blood urine present | |
| 125950592 | 12595059 | CSF white blood cell count increased | |
| 125950592 | 12595059 | Colonic pseudo-obstruction | |
| 125950592 | 12595059 | Depressed level of consciousness | |
| 125950592 | 12595059 | Graft versus host disease | |
| 125950592 | 12595059 | Groin pain | |
| 125950592 | 12595059 | Haematoma | |
| 125950592 | 12595059 | Hypoxia | |
| 125950592 | 12595059 | Leukocytosis | |
| 125950592 | 12595059 | Mental status changes | |
| 125950592 | 12595059 | Muscle rigidity | |
| 125950592 | 12595059 | Muscular weakness | |
| 125950592 | 12595059 | Musculoskeletal stiffness | |
| 125950592 | 12595059 | Pancreatic cyst | |
| 125950592 | 12595059 | Pericardial effusion | |
| 125950592 | 12595059 | Pleural effusion | |
| 125950592 | 12595059 | Pneumonia | |
| 125950592 | 12595059 | Posterior reversible encephalopathy syndrome | |
| 125950592 | 12595059 | Pseudomonas infection | |
| 125950592 | 12595059 | Pyrexia | |
| 125950592 | 12595059 | Respiratory distress | |
| 125950592 | 12595059 | Rhabdomyolysis | |
| 125950592 | 12595059 | Staphylococcal infection | |
| 125950592 | 12595059 | Systemic inflammatory response syndrome | |
| 125950592 | 12595059 | Varicella zoster virus infection | |
| 125950592 | 12595059 | White matter lesion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125950592 | 12595059 | 1 | 2011 | 20160510 | 0 | |
| 125950592 | 12595059 | 3 | 20160510 | 0 | ||
| 125950592 | 12595059 | 4 | 20160510 | 0 | ||
| 125950592 | 12595059 | 5 | 20160510 | 0 | ||
| 125950592 | 12595059 | 10 | 201208 | 20160320 | 0 | |
| 125950592 | 12595059 | 11 | 20160511 | 0 | ||
| 125950592 | 12595059 | 12 | 20160511 | 0 | ||
| 125950592 | 12595059 | 16 | 20160511 | 0 |